SRF388
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SRF388, covering 2026-03-18 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma [Phase 2]